Tjoapack is expanding its oral solid dose (OSD) bottle packaging capabilities at its Etten-Leur, Netherlands, facility, enhancing flexibility, efficiency, and GMP-compliant packaging options to meet growing demand.
Company announces two new additional manufacturing facilities to be built in North Carolina and Pennsylvania; continues to deliver on $55 billion US investment.
AbbVie will acquire West Pharmaceutical Services’ Tempe, Arizona, manufacturing facility for over $175 million to expand US drug delivery device capacity, with closing expected mid-2026.
Sharp Sterile Manufacturing announced a $28 million expansion of its Lee, Massachusetts site to boost pharmaceutical production capacity and create high-skilled life sciences jobs.
Optex Innovation Center launches as an independent extrusion coating pilot for flexible packaging.
Ineos is investing £150 million at its Grangemouth site, supported by a £75 million government loan guarantee and a £50 million grant.
Fourth major US manufacturing investment announced this year, advancing AstraZeneca’s historic $50 billion commitment to medicines manufacturing and R&D.
New capacity of specialty lubricants to accelerate business growth and innovation in the region.
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness.
Novartis plans to establish a flagship manufacturing hub in North Carolina by 2027-2028 as part of a $23 billion investment in US infrastructure.
Ineos has launched a major investment at Lavera to regenerate and modernize one of France’s most important industrial sites, safeguarding 10,000 jobs, with support from the French State.
Nouryon has opened a new innovation center in Shanghai to boost localized innovation, customer collaboration, and sustainable development in key industries across China and the Asia Pacific region.
Curia has completed a $4 million upgrade to its sterile API manufacturing suites in Valladolid, Spain, to enhance product quality, safety, and regulatory compliance.
SK Pharmteco has announced a $6.1 million investment to expand its Rancho Cordova, California, facility with new lab and kilo-scale capabilities for solid-phase peptide synthesis and purification.
Aenova will install an additional filling and manufacturing line at the Latina, Italy, site. This expansion is an important step to meet the increasing global demand for the production of biologics.
Investments will bolster clinical and commercial capacity in US and Europe facilities for injectable and oral solid dose packaging, and sterile filling.
Cambrex announced a $120 million investment to expand its API manufacturing capacity at its Charles City, Iowa, facility by 40%.
The investment will focus on developing gelatin and HPMC facilities, creating over 200 new jobs, and strengthening ACG’s 25-year presence in the US, with operations expected to begin in early 2027.
The Leeds Innovation & Application Center is the newest of the now 71 Brenntag Specialties innovation centers globally, 31 of which focus on Food & Nutrition.
Roquette has inaugurated a new Pharmaceutical Innovation Center in Brazil to support advanced research and development in the region’s pharmaceutical sector.
Clariant successfully completes its CHF 100 million investment in the Daya Bay plant in China, with the second production line becoming fully operational in November.
Polyvantis has opened a new Technology Center in Shanghai, China, to unite R&D, commercial, and manufacturing teams and accelerate innovation for optical and electrical film solutions.
Fujifilm Biotechnologies has opened one of North America's largest commercial-scale cell culture biomanufacturing sites in Holly Springs, North Carolina, US.
Henkel has doubled the size of its South Dakota plant to increase production of thermal management materials for the electric vehicle and electronics markets.
Arkema has inaugurated a new laboratory in Normandy dedicated to dry coating processes for battery electrodes, aiming to advance sustainable manufacturing by reducing energy use and developing new battery solutions.
New state-of-the-art active pharmaceutical ingredient (API) facility in North Chicago will manufacture immunology, oncology, and neuroscience medicines.
Dinamiqs, a Siegfried company specialized in viral vector design and manufacturing, inaugurated its new cGMP manufacturing facility.
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Houston, Texas.
BASF and cooperation partner GIG Karasek have celebrated the symbolic ground-breaking ceremony for one of the world's largest industrial heat pumps for CO2-free steam generation at the Ludwigshafen site.
Merck's first climate-neutral production facility has opened at its Blarney site in Cork, Ireland. The €150 million new building is part of the group's €440 million investment program in Ireland.
Solvay strengthens its competitiveness in Germany through portfolio realignment and investments.
Includes $1.2 billion in manufacturing facilities, AI, and advanced digital technologies, creating hundreds of highly skilled US jobs.
LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, Canada.
New Bay Area building marks significant progress as part of Gilead's $32 billion US investment.
Honeywell’s Quantinuum has raised $600 million at a $10 billion valuation, with Nvidia and other key investors backing the company to accelerate development of advanced quantum technologies and global partnerships.
